Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |